Thrombosis: all 1,528 studies

Page 15 of 16. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and OutcomeStatus unknownNCT00588757Not applicable
• Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1CompletedNCT00574665Not applicable
• Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in NeonatesCompletedNCT00555932Not applicable
• Birth Control Pill vs Birth Control Patch StudyCompletedNCT00554632Not applicable
• 3 Screen Electronic AlertCompletedNCT00550082
• Registry of Hospitalized Patients Treated With FondaparinuxCompletedNCT00549705
• Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial InfarctionCompletedNCT00539045
• Venous Thromboembolism Taskforce Audit ProgramCompletedNCT00535171
• Atorvastatin for the Treatment of Retinal Vein OcclusionStatus unknownNCT00517257Phase 3
• Antiplatelet Drug Resistances and Ischemic EventsCompletedNCT00501423
• XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin PrescribingStatus unknownNCT00484640Not applicable
• Evaluating the Role of Thrombin in Saphenous Vein Graft Failure After Heart Bypass SurgeryStatus unknownNCT00481806
• Anticoagulant Therapy During Pacemaker ImplantationCompletedNCT00479362Phase 4
• Thrombophilia and Migraine, Are They Related?CompletedNCT00457184
• PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava InterruptionCompletedNCT00457158Phase 4
• Epidemiology of Venous ThromboembolismCompletedNCT00456196
• Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein ThrombosisStatus unknownNCT00450645Phase 4
• Efficacy and Safety of Natto ExtractCompletedNCT00447434Phase 4
• Active Detection of the Extension of Atherothrombosis in High Risk Coronary PatientsCompletedNCT00445835Not applicable
• Residual Vein Thrombosis Establishes the Optimal Duration of Oral AnticoagulantsCompletedNCT00438230Phase 4
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese VolunteersCompletedNCT00436787Phase 2
• Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy VolunteersCompletedNCT00432770Phase 1
• Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVTTerminatedNCT00428129Phase 2
• Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic SyndromeCompletedNCT00426075Phase 3
• Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and ThrombosisCompletedNCT00422396Not applicable
• Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)CompletedNCT00421538Phase 3
• Fondaparinux as Monotherapy for DVT and/or Pulmonary EmbolismCompletedNCT00413504Not applicable
• Multi-Center Human Alert Trial to Prevent DVT and PECompletedNCT00409136
• Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein ThrombosisCompletedNCT00395772Phase 2
• Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic SyndromeCompletedNCT00395265
• Ultrasound Findings to Adjust the Duration of AnticoagulationCompletedNCT00380120Phase 3
• External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular AccessTerminatedNCT00379366Phase 2/3
• 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PECompletedNCT00365950Phase 4
• The Association of Platelet Function and Endothelial Function of the Brachial ArteryCompletedNCT00363818
• Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein ThrombosisCompletedNCT00362947Phase 3
• The ERASMUS Study: Limited vs Extended US for DVT DiagnosisCompletedNCT00353093Not applicable
• Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac ArteriesCompletedNCT00352222Phase 3
• The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsCompletedNCT00351663Phase 4
• Xtract™ Aspiration Catheter Registry StudyCompletedNCT00349570Not applicable
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central CathetersCompletedNCT00346424Phase 3
• Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic ApproachCompletedNCT00345618Phase 3
• Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for SurgeryTerminatedNCT00338585Phase 3
• Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery OcclusionStatus unknownNCT00336596Phase 3
• US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance StatusCompletedNCT00336258
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"CompletedNCT00334464Not applicable
• Single Comprehensive Ultrasound to Rule Out DVT in High-risk PatientsCompletedNCT00333697Not applicable
• Monitoring Response to Antiplatelet TherapyStatus unknownNCT00327041
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded CathetersCompletedNCT00322270Phase 3
• LV Thrombus Pilot Study for Comparing Enoxaparin Vs. WarfarinCompletedNCT00321009Not applicable
• VITRO-Trial. B Vitamins and the Secondary Prevention of Venous ThrombosisCompletedNCT00314990Not applicable
• Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate CancerCompletedNCT00312013Phase 3
• Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)TerminatedNCT00311896Phase 3
• Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsCompletedNCT00311090Phase 3
• Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee SurgeryCompletedNCT00306254Phase 2
• Alteplase for Blood Flow Restoration in Hemodialysis CathetersTerminatedNCT00303420Phase 4
• TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis TechniqueStatus unknownNCT00294814Not applicable
• Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer PatientsCompletedNCT00285038
• D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of RecurrenceCompletedNCT00266045
• Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and InfantsTerminatedNCT00265005Phase 1
• D-dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNCT00264277Phase 4
• Understanding Risk Factors Involved in Developing a Second Blood Clot.Status unknownNCT00261014
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT StudyCompletedNCT00252005Phase 2
• Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein ThrombosisCompletedNCT00251771Not applicable
• Cystic Fibrosis and Totally Implantable Vascular Access DevicesCompletedNCT00244270Phase 4
• Risk of Developing Antibodies to Heparin-PF4 After Heart SurgeryCompletedNCT00237328
• A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show ClotsCompletedNCT00232622Phase 3
• The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.TerminatedNCT00232271Phase 4
• The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean SectionCompletedNCT00225108Phase 2/3
• Aspirin for the Prevention of Recurrent Venous ThromboembolismStatus unknownNCT00222677Phase 2/3
• The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein ThrombosisCompletedNCT00216866Phase 2
• A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)CompletedNCT00211146Phase 3
• Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine ServicesActive, not recruitingNCT00203970
• Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by WarfarinCompletedNCT00203658Phase 4
• Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)CompletedNCT00203580Phase 4
• Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer PatientsCompletedNCT00199602Phase 3
• Efficacy and Safety Study of Argatroban to Treat Heparin-Induced ThrombocytopeniaCompletedNCT00198588Phase 3
• STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary SurgeryCompletedNCT00190307Phase 4
• The D-KAF (Dalteparin in Knee-to-Ankle Fracture) TrialCompletedNCT00187408Phase 4
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney FailureTerminatedNCT00186745Not applicable
• Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.CompletedNCT00185952Not applicable
• Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)TerminatedNCT00182546Phase 3
• Fixed Dose Heparin StudyCompletedNCT00182403Phase 3
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)CompletedNCT00182364Phase 3
• D-Dimer Vs Serial Compression Ultrasound StudyCompletedNCT00182351Phase 3
• D-Dimer and IPG for Recurrent Thrombosis (DIRECT)TerminatedNCT00182247Phase 3
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)CompletedNCT00182143Phase 3
• Sonography Outcomes Assessment Program for Lower Extremity Deep Venous ThrombosisCompletedNCT00178789
• The Use of Low Molecular Weight Heparin in Traumatic Brain InjuryCompletedNCT00170378Phase 4
• Genetic Determinants of Warfarin Anticoagulation EffectStatus unknownNCT00162435Not applicable
• Epidemiology Study in Major Orthopaedic SurgeryCompletedNCT00159185
• Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)CompletedNCT00157677Phase 3
• Long Study - Longitudinal Thrombosis in End Stage Renal DiseaseStatus unknownNCT00157664
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis CathetersCompletedNCT00157651Phase 3
• MDA D-Dimer / Recurrent DVT StudyCompletedNCT00157599Not applicable
• Oral Vitamin K for Warfarin Associated CoagulopathyCompletedNCT00143715Phase 3
• Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)CompletedNCT00119457Phase 2
• Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the FootCompletedNCT00114608Phase 1
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00097357Phase 2/3
• Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)CompletedNCT00073580Phase 3

← Thrombosis overview